Transforming Plastic Waste into Parkinson's Drug: A Breakthrough at the University of Edinburgh

Researchers at the University of Edinburgh have developed a groundbreaking method to convert polyethylene terephthalate (PET) plastic waste into L-DOPA (levodopa), a primary treatment for Parkinson’s disease. This innovative approach utilizes genetically engineered Escherichia coli (E. coli) bacteria to transform discarded plastic bottles into a valuable pharmaceutical compound. The findings, published in the journal *Nature Sustainability*, highlight a sustainable alternative to traditional fossil fuel-based drug manufacturing.

Plastic waste turned into Parkinson’s Drug L-DOPA in breakthrough discoveryInteresting EngineeringE. coli Converts Plastic Waste Into Parkinson’s Drug L-DOPAPlastic bottles recycled into Parkinson's drug using bacteria

The process begins with breaking down PET plastic into terephthalic acid, a chemical building block. The engineered E. coli then convert this acid into L-DOPA through a series of biological reactions. This method not only addresses the growing problem of plastic pollution—approximately 50 million tonnes of single-use plastic are produced annually—but also repurposes waste into a life-saving medication.

E. coli Converts Plastic Waste Into Parkinson’s Drug L-DOPAPlastic waste turned into Parkinson’s Drug L-DOPA in breakthrough discoveryThe plastic bottle that became a Parkinson’s drugPlastic bottles recycled into Parkinson's drug using bacteria

The traditional production of L-DOPA relies heavily on petroleum-derived precursors and is energy-intensive, contributing to carbon emissions and environmental degradation. In contrast, the new method offers a cleaner synthesis route, reducing reliance on toxic chemicals and minimizing hazardous waste. Professor Stephen Wallace, a lead researcher, emphasized the potential of this technology, stating, “If we can create medicines for neurological diseases from waste plastic bottles, it’s exciting to imagine what else this technology could achieve.”

Plastic waste turned into Parkinson’s Drug L-DOPA in breakthrough discoveryThe Irish NewsE. coli Converts Plastic Waste Into Parkinson’s Drug L-DOPA

The researchers aim to optimize the process for industrial application, focusing on scalability and environmental performance. They have already demonstrated the feasibility of producing L-DOPA at a scale of 0.9 grams per liter from PET waste, with potential for further increases using industrial plastic waste.

The plastic bottle that became a Parkinson’s drug

Despite the promising results, some experts caution against viewing this method as a comprehensive solution to plastic pollution. Critics argue that while bio-upcycling represents a significant advancement, it should not replace efforts to reduce plastic production and consumption. Parley for the Oceans founder Cyrill Gutsch has urged for continued focus on minimizing plastic use rather than relying on technological fixes.

Plastic bottles recycled into Parkinson's drug using bacteria

The research team acknowledges that further development is necessary before this method can be implemented on an industrial scale. Current challenges include the need for antibiotic selection in engineered bacteria, which will not be feasible in large-scale production. The researchers are exploring ways to integrate the biosynthetic pathway into microbial genomes to address this issue.

E. coli Converts Plastic Waste Into Parkinson’s Drug L-DOPA

The implications of this research extend beyond L-DOPA production. The team envisions a future where similar bio-upcycling techniques could be applied to create a range of products, including flavorings, fragrances, and industrial chemicals. This approach not only offers a potential pathway for sustainable pharmaceutical manufacturing but also contributes to a circular bioeconomy by transforming waste into high-value resources.

The Irish News

As the University of Edinburgh's research progresses, the focus will remain on refining the technology and assessing its broader environmental impacts. The potential to convert plastic waste into essential medicines marks a significant step forward in both pharmaceutical innovation and environmental sustainability.

The Irish News

• “If we can create medicines for neurological disease from a waste plastic bottle, it's exciting to imagine what else this technology could achieve.” — Professor Stephen Wallace, University of Edinburgh

Plastic bottles recycled into Parkinson's drug using bacteria

• “Turning plastic bottles into a Parkinson’s drug isn’t just a creative recycling idea, it’s a way of redesigning processes that work with nature to deliver real-world benefits,” — Dr. Liz Fletcher, Industrial Biotechnology Innovation Centre

Interesting Engineering

• “By converting discarded plastic into a treatment for Parkinson’s disease, the University of Edinburgh team has demonstrated how carbon that would otherwise be lost to landfill or pollution can be turned into high-value products that improve lives.” — Professor Charlotte Deane, UKRI EPSRC

The Irish News

This research represents a significant advancement in sustainable drug production, showcasing the potential of engineering biology to address pressing environmental challenges while improving human health.

The Irish News